However, due to the opposite direction of changes in the relative content of phospholipid classes observed in this study and large differences in clinical parameters (especially CRP and LDH) between COVID-19 patients who have died, we decided to divide this group into two subgroups, including 15 and 5 patients in the first and second groups, respectively (Table 2). The gene discussed is CRP; the disease is COVID-19.